PNC Financial Services Group
IMVT icon

PNC Financial Services Group’s Immunovant IMVT Stock Holding History

PNC Financial Services Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.1K Buy
2,902
+123
+4% +$3.18K ﹤0.01% 3007
2025
Q4 		$70.6K Sell
2,779
-52
-2% -$1.16K ﹤0.01% 3015
2025
Q3 		$45.6K Buy
2,831
+1,646
+139% +$26.6K ﹤0.01% 3257
2025
Q2 		$19K Buy
1,185
+1,047
+759% +$15.8K ﹤0.01% 3598
2025
Q1 		$2.36K Buy
138
+59
+75% +$1.23K ﹤0.01% 4297
2024
Q4 		$1.96K Buy
79
+24
+44% +$681 ﹤0.01% 4288
2024
Q3 		$1.57K Sell
55
-110
-67% -$3.24K ﹤0.01% 4336
2024
Q2 		$4.36K Sell
165
-30
-15% -$853 ﹤0.01% 4032
2024
Q1 		$6.3K Sell
195
-22
-10% -$803 ﹤0.01% 3893
2023
Q4 		$9.14K Sell
217
-71
-25% -$2.61K ﹤0.01% 3757
2023
Q3 		$11.1K Buy
+288
New +$6.51K ﹤0.01% 3710
2023
Q1 		– Sell
-45,601
Closed -$809K – 4755
2022
Q4 		$809K Hold
45,601
– – ﹤0.01% 1242
2022
Q3 		$254K Hold
45,601
– – ﹤0.01% 1934
2022
Q2 		$178K Sell
45,601
-131
-0.3% -$566 ﹤0.01% 2226
2022
Q1 		$252K Sell
45,732
-402
-0.9% -$2.5K ﹤0.01% 2109
2021
Q4 		$393K Buy
46,134
+10,389
+29% +$85.8K ﹤0.01% 1854
2021
Q3 		$311K Buy
+35,745
New +$322K ﹤0.01% 1919

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PNC Financial Services Group's IMVT Position: Q1 2026 in Review

PNC Financial Services Group increased its Immunovant (IMVT) stake by 4.4% in Q1 2026, buying an estimated $3.18K and bringing the position to 2,902 shares worth $72.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3007.

PNC Financial Services Group first reported a position in IMVT in Q3 2021 and has held it in 17 quarters since. The position peaked at $809K in Q4 2022. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • PNC Financial Services Group held 2,902 shares of Immunovant worth $72.1K as of Q1 2026.
  • PNC Financial Services Group bought 123 Immunovant shares in Q1 2026, an estimated $3.18K.
  • Immunovant made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3007 holding.
  • PNC Financial Services Group first reported a position in Immunovant in Q3 2021 and has held it in 17 quarters since.
  • PNC Financial Services Group's Immunovant position peaked at $809K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.